Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery

Craik, 2013, The future of peptide-based drugs, Chem. Biol. Drug Des., 81, 136, 10.1111/cbdd.12055 Vrignaud, 2011, Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles, Biomaterials, 32, 8593, 10.1016/j.biomaterials.2011.07.057 Xu, 2012, A quality by design (QbD) case study on liposomes containing hydrophilic API:II. Screening of critical variables, and establishment of design space at laboratory scale, Int. J. Pharm., 423, 543, 10.1016/j.ijpharm.2011.11.036 Patel, 2011, Colloidal delivery systems in foods: a general comparison with oral drug delivery, LWT-Food Sci. Technol., 44, 1958, 10.1016/j.lwt.2011.04.005 Matsumura, 1986, A new concept for macromolecular therapeutics in cancer chemotherapy; mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS, Cancer Res., 46, 6387 Klibanov, 1990, Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Lett., 268, 235, 10.1016/0014-5793(90)81016-H Allen, 1991, Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta, 1066, 29, 10.1016/0005-2736(91)90246-5 Torchilin, 2005, Recent advances with liposomes as pharmaceutical carriers, Nat. Rev. Drug Discov., 2, 145, 10.1038/nrd1632 Yamamoto, 2007, What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core, J. Control. Release, 123, 11, 10.1016/j.jconrel.2007.07.008 Xu, 2012, Predicting hydrophilic drug encapsulation inside unilamellar liposomes, Int. J. Pharm., 423, 410, 10.1016/j.ijpharm.2011.12.019 Cortesi, 1999, Preparation of liposomes by reverse-phase evaporation using alternative organic solvents, J. Microencapsul., 16, 251, 10.1080/026520499289220 Mayer, 1985, Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles, Biochim. Biophys. Acta, 817, 193, 10.1016/0005-2736(85)90084-7 Haran, 1993, Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases, Biochim. Biophys. Acta, 1151, 201, 10.1016/0005-2736(93)90105-9 Barenholz, 2012, Doxil® — the first FDA-approved nano-drug: lessons learned, J. Control. Release, 160, 117, 10.1016/j.jconrel.2012.03.020 Bibi, 2012, Trigger release liposome systems: local and remote controlled delivery?, J. Microencapsul., 29, 262, 10.3109/02652048.2011.646330 Allen, 2013, Liposomal drug delivery systems: from concept to clinical applications, Adv. Drug Deliv. Rev., 65, 36, 10.1016/j.addr.2012.09.037 Kepczynski, 2008, Which physical and structural factors of liposome carriers control their drug-loading efficiency?, Chem. Phys. Lipids, 155, 7, 10.1016/j.chemphyslip.2008.05.174 Taylor, 1990, Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes, Int. J. Pharm., 58, 49, 10.1016/0378-5173(90)90286-D Manojlovic, 2008, Membrane interactions of ternary phospholipid/cholesterol bilayers and encapsulation efficiencies of a RIP II protein, Colloids Surf. B: Biointerfaces, 64, 284, 10.1016/j.colsurfb.2008.02.001 Glavas-Dodov, 2005, The effects of lyophilization on the stability of liposomes containing 5-FU, Int. J. Pharm., 291, 79, 10.1016/j.ijpharm.2004.07.045 Di Giulio, 1991, Encapsulation of ampicillin in reverse-phase evaporation liposomes: a direct evaluation by derivative spectrophotometry, Int. J. Pharm., 74, 183, 10.1016/0378-5173(91)90235-G Zamboni, 2004, Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma, Cancer Chemother. Pharmacol., 53, 329, 10.1007/s00280-003-0719-4 Chaudhury, 2012, Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration, Int. J. Pharm., 430, 167, 10.1016/j.ijpharm.2012.04.036 Gürsoy, 2004, Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy, Int. J. Pharm., 271, 115, 10.1016/j.ijpharm.2003.10.033 Han, 2012, Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system, Eur. J. Pharm. Sci., 46, 500, 10.1016/j.ejps.2012.04.002 Moghaddam, 2011, The application of monolayer studies in the understanding of liposomal formulations, Int. J. Pharm., 417, 235, 10.1016/j.ijpharm.2011.01.020 Schneider, 1995, Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method, Int. J. Pharm., 117, 1, 10.1016/0378-5173(94)00245-Z Belletti, 2011, Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes, Int. J. Pharm., 413, 220, 10.1016/j.ijpharm.2011.04.025 Wang, 2013, Preparation and evaluation of lidocaine hydrochloride-loaded TAT-conjugated polymeric liposomes for transdermal delivery, Int. J. Pharm., 441, 748, 10.1016/j.ijpharm.2012.10.019 Villasmil-Sánchez, 2013, Thermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. comparative 31P-NMR analysis on negatively and positively-charged liposomes, Colloids Surf. B: Biointerfaces, 105, 14, 10.1016/j.colsurfb.2012.12.019 Kajiwara, 2007, Long-circulating liposome encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy, J. Control. Release, 120, 104, 10.1016/j.jconrel.2007.04.011 Ruozi, 2010, Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma, Eur. J. Pharm. Sci., 41, 254, 10.1016/j.ejps.2010.06.012 Bangham, 1965, Diffusion of univalent ions across the lamellae of swollen phospholipids, J. Mol. Biol., 13, 238, 10.1016/S0022-2836(65)80093-6 Szoka, 1978, Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation, Proc. Natl. Acad. Sci. U.S.A., 75, 4194, 10.1073/pnas.75.9.4194 Zadi, 2000, A novel method for high-yield entrapment of solutes into small liposomes, J. Liposome Res., 10, 73, 10.3109/08982100009031096 Castile, 1999, Factors affecting the size distribution of liposomes produced by freeze–thaw extrusion, Int. J. Pharm., 188, 87, 10.1016/S0378-5173(99)00207-0 Chapman, 1990, Factors affecting solute entrapment in POPC vesicles prepared by the freeze–thaw extrusion method, Chem. Phys. Lipids, 55, 73, 10.1016/0009-3084(90)90068-3 Anzai, 1990, Change in intravesicular volume of liposomes by freeze–thaw treatment as studied, Biochim. Biophys. Acta, 1021, 21, 10.1016/0005-2736(90)90378-2 Ueno, 2005, Effect of PEG lipid on fusion and fission of phospholipid vesicles in the process of freeze-thawing, Polymer, 46, 1257, 10.1016/j.polymer.2004.11.050 Hope, 1985, Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential, Biochim. Biophys. Acta, 812, 55, 10.1016/0005-2736(85)90521-8 Agashe, 2010, Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid, Colloids Surf. B: Biointerfaces, 75, 573, 10.1016/j.colsurfb.2009.09.038 Akbarzadeh, 2013, Lipossome: classification, preparation and applications, Nanoscale Res. Lett., 8, 1, 10.1186/1556-276X-8-102 Vemuri, 1995, Preparation and characterization of liposomes as therapeutic delivery systems: a review, Pharm. Acta Helv., 70, 95, 10.1016/0031-6865(95)00010-7 Elorza, 1993, Characterization of 5-fluorouracil loaded liposomes prepared by reverse-phase evaporation or freezing-thawing extrusion methods: study of drug release, Biochim. Biophys. Acta, 1153, 135, 10.1016/0005-2736(93)90398-J Zhang, 2012, The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B, Fitoterapia, 83, 678, 10.1016/j.fitote.2012.02.004 Muppidi, 2012, Development and stability studies of novel liposomal vancomycin formulations, ISRN Pharm., 2012, 1 Patil, 2014, Novel methods for liposome preparation, Chem. Phys. Lipids, 177, 8, 10.1016/j.chemphyslip.2013.10.011 Davies, 2012, Formation of liposomes using a 3D flow focusing microfluidic device with spatially patterned wettability by corona discharge, J. Micromech. Microeng., 22, 1, 10.1088/0960-1317/22/5/055003 Shum, 2008, Double emulsion templated monodisperse phospholipid vesicles, Langmuir, 24, 7651, 10.1021/la801833a Deamer, 1972, The response of fluorescent amines to pH gradients across liposome membranes, Biochim. Biophys. Acta, 274, 323, 10.1016/0005-2736(72)90180-0 Nichols, 1976, Catecholamine uptake and concentration by liposomes maintaining pH gradients, Biochim. Biophys. Acta, 455, 269, 10.1016/0005-2736(76)90169-3 Ishida, 2002, Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes, Int. J. Pharm., 232, 59, 10.1016/S0378-5173(01)00896-1 Hwang, 1999, Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods, Int. J. Pharm., 179, 85, 10.1016/S0378-5173(98)00392-5 Clerc, 1998, A quantitative model for using acridine organge as a transmembrane pH gradient probe, Anal. Biochem., 259, 104, 10.1006/abio.1998.2639 Li, 1998, Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient, Biochim. Biophys. Acta, 1415, 23, 10.1016/S0005-2736(98)00175-8 Zucker, 2009, Liposome drugs’ loading efficiency: a working model based on loading conditions and drug's physicochemical properties, J. Control. Release, 139, 73, 10.1016/j.jconrel.2009.05.036 Clerc, 1995, Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients, Biochim. Biophys. Acta, 1240, 257, 10.1016/0005-2736(95)00214-6 Dos Santos, 2004, pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol, Biochim. Biophys. Acta, 1661, 47, 10.1016/j.bbamem.2003.11.016 Fritze, 2006, Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient, Biochim. Biophys. Acta, 1758, 1633, 10.1016/j.bbamem.2006.05.028 Abrahama, 2004, An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes, J. Control. Release, 96, 449, 10.1016/j.jconrel.2004.02.017 Li, 2008, Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release, Eur. J. Pharm. Sci., 34, 333, 10.1016/j.ejps.2008.05.006 Cui, 2009, Ni2+-mediated mitoxantrone encapsulation: Improved efficacy of fast release formulation, Int. J. Pharm., 368, 24, 10.1016/j.ijpharm.2008.09.045 Cern, 2012, Quantitative structure–property relationship modeling of remote liposome loading of drugs, J. Control. Release, 160, 147, 10.1016/j.jconrel.2011.11.029 Wong, 2003, Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection, J. Control. Release, 92, 265, 10.1016/S0168-3659(03)00358-4 Qiu, 2008, Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method, Int. J. Pharm., 361, 56, 10.1016/j.ijpharm.2008.05.010 Sun, 2012, Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid–drug complex and its pharmacokinetic features in Sprague–Dawley rats, Eur. J. Pharm. Biopharm., 80, 323, 10.1016/j.ejpb.2011.10.014 Hwang, 2011, Fabrication of nano-scale liposomes containing doxorubicin using Shirasu porous glass membrane, Colloids Surf. A: Physicochem. Eng. Aspects, 392, 250, 10.1016/j.colsurfa.2011.09.063 Lee, 1995, Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro, Biochim. Biophys. Acta, 1233, 134, 10.1016/0005-2736(94)00235-H Han, 2006, In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes, Int. J. Pharm., 313, 181, 10.1016/j.ijpharm.2006.02.007 Takeuchi, 1999, Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats, Eur. J. Pharm. Biopharm., 48, 123, 10.1016/S0939-6411(99)00029-6 Stensrud, 2000, Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design, Int. J. Pharm., 198, 213, 10.1016/S0378-5173(00)00338-0 Kizelsztein, 2009, Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis, J. Neuroimmunol., 213, 20, 10.1016/j.jneuroim.2009.05.019 Zucker, 2012, Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy, J. Control. Release, 160, 281, 10.1016/j.jconrel.2011.10.003 Tokudome, 1996, Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma, Biochim. Biophys. Acta, 1279, 70, 10.1016/0005-2736(95)00242-1 Maeda, 2000, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, J. Control. Release, 65, 271, 10.1016/S0168-3659(99)00248-5 Maeda, 2003, Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications, Int. Immunopharmacol., 3, 319, 10.1016/S1567-5769(02)00271-0 Palmer, 1984, The mechanism of liposome accumulation in infarction, Biochim. Biophys. Acta, 797, 363, 10.1016/0304-4165(84)90258-7 Kelly, 2011, Targeted liposomal drug delivery to monocytes and macrophages, J. Drug Deliv., 2011, 1, 10.1155/2011/727241 Andresen, 2005, Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release, Prog. Lipid Res., 44, 68, 10.1016/j.plipres.2004.12.001 Li, 2013, Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy, J. Control. Release, 168, 142, 10.1016/j.jconrel.2013.03.011 Wu, 2011, Epirubicin-encapsulated long-circulating thermosensitive liposome improves pharmacokinetics and antitumor therapeutic efficacy in animals, J. Liposome Res., 21, 221, 10.3109/08982104.2010.520273 Zhang, 2011, Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate, Int. J. Pharm., 414, 56, 10.1016/j.ijpharm.2011.05.013 Ferreira, 2012, Technetium-99m-labeled ceftizoxime loaded long-circulating and pH-sensitive liposomes used to identify osteomyelitis, Bioorg. Med. Chem. Lett., 22, 4605, 10.1016/j.bmcl.2012.05.105 Morilla, 2005, Etanidazole in pH-sensitive liposomes: design, characterization and in vitro/in vivo anti-Trypanosoma cruzi activity, J. Control. Release, 103, 599, 10.1016/j.jconrel.2004.12.012 Torres, 2011, Improved paramagnetic liposomes for MRI visualization of pH triggered release, J. Control Release, 154, 196, 10.1016/j.jconrel.2011.05.017 Huang, 2004, Acoustically active liposomes for drug encapsulation and ultrasound-triggered release, Biochim. Biophys. Acta, 1665, 134, 10.1016/j.bbamem.2004.07.003 Huang, 2008, A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery, Ultrasound. Med. Biol., 34, 1272, 10.1016/j.ultrasmedbio.2008.01.005 Kee, 2008, Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery, J. Liposome Res., 18, 263, 10.1080/08982100802354558 Babincová, 2002, AC-magnetic field controlled drug release from magnetoliposomes: design of a method for site-specific chemotherapy, Bioelectrochemistry, 55, 17, 10.1016/S1567-5394(01)00171-2 Nappini, 2010, Magnetoliposomes for controlled drug release in the presence of low-frequency magnetic field, Soft Matter, 6, 154, 10.1039/B915651H Saiyed, 2010, Magnetic nanoformulation of azidothymidine 5′-triphosphate for targeted delivery across the blood–brain barrier, Int. J. Nanomed., 5, 157 Yavlovich, 2011, A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cells, Biochim. Biophys. Acta, 1808, 117, 10.1016/j.bbamem.2010.07.030 Kulshrestha, 2012, In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia, Colloids Surf. B: Biointerfaces, 96, 1, 10.1016/j.colsurfb.2012.02.029 Yan, 2013, Paclitaxel-liposome–microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers, J. Control. Release, 166, 246, 10.1016/j.jconrel.2012.12.025 Kopechek, 2008, Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes, J. Ultrasound. Med., 27, 1597, 10.7863/jum.2008.27.11.1597 Drummond, 1999, Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors, Pharmacol. Rev., 51, 691 Durazo, 2011, Functionalized nanosystems for targeted mitochondrial delivery, Mithocondrion, 12, 190, 10.1016/j.mito.2011.11.001 Koren, 2012, Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity, J. Control. Release, 160, 264, 10.1016/j.jconrel.2011.12.002 Fang, 2011, The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect, Adv. Drug Deliv. Rev., 63, 136, 10.1016/j.addr.2010.04.009 Maeda, 1992, Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo, Bioconjug. Chem., 3, 351, 10.1021/bc00017a001 Jain, 1999, Transport of molecules, particles and cells in solid tumors, Annu. Rev. Biomed. Eng., 1, 241, 10.1146/annurev.bioeng.1.1.241 Jain, 2001, Delivery of molecular and cellular medicine to solid tumors, Adv. Drug Deliv. Rev., 46, 149, 10.1016/S0169-409X(00)00131-9 Tanaka, 2009, Nanotechnology for breast cancer therapy, Biomed. Microdev., 11, 49, 10.1007/s10544-008-9209-0 Maruyama, 2011, Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects, Adv. Drug Deliv. Rev., 63, 161, 10.1016/j.addr.2010.09.003 Stapleton, 2013, A mathematical model of the enhanced permeability and retention effect for liposome transport in solid tumors, PLoS ONE, 8, 1, 10.1371/journal.pone.0081157 Li, 2008, Polymer-drug conjugates: recent development in clinical oncology, Adv. Drug Deliv. Rev., 60, 886, 10.1016/j.addr.2007.11.009 Petre, 2007, Liposomal daunorubicin as treatment for Kaposi's Sarcoma, Int. J. Nanomed., 2, 277 Nakamura, 2006, A polymeric micelle MRI contrast agent with changeable relaxivity, J. Control Release, 114, 325, 10.1016/j.jconrel.2006.05.030 Shiraishi, 2009, Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents, J. Control Release, 136, 14, 10.1016/j.jconrel.2009.01.010 Shiraishi, 2010, Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T1-relaxivities and blood circulation characteristics, J. Control Release, 148, 160, 10.1016/j.jconrel.2010.08.018 Yokoyama, 2011, Clinical applications of polymeric micelle carrier systems in chemotherapy and image diagnosis of solid tumors, J. Exp. Clin. Med., 3, 151, 10.1016/j.jecm.2011.06.002 Folkman, 1992, Angiogenesis, J. Biol. Chem., 267, 10931, 10.1016/S0021-9258(19)49853-0 Holmgren, 1995, Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression, Nat. Med., 1, 149, 10.1038/nm0295-149 Alves-Rosa, 2000, Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model, Blood, 96, 2834, 10.1182/blood.V96.8.2834 Claassen, 1990, A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage ‘suicide’ technique, J. Immunol. Methods, 134, 153, 10.1016/0022-1759(90)90376-7 Van Rooijen, 1994, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J. Immunol. Methods, 174, 83, 10.1016/0022-1759(94)90012-4 Jordan, 2003, Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model, Blood, 101, 594, 10.1182/blood-2001-11-0061 Summan, 2006, Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study, Am. J. Physiol. Regul. Integr. Comp. Physiol., 290, 1488, 10.1152/ajpregu.00465.2005 Moen, 2009, Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections, Drugs, 69, 361, 10.2165/00003495-200969030-00010 Bakker-Woudenberg, 1986, Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages, Antimicrob. Agents Chemother., 30, 295, 10.1128/AAC.30.2.295 Majumdar, 1992, Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages, Antimicrob. Agents Chemother., 36, 2808, 10.1128/AAC.36.12.2808 Kende, 1985, Enhanced efficacy of liposome-encapsulated ribavarin against Rift valley fever virus infection in mice, Antimicrob. Agents Chemother., 27, 903, 10.1128/AAC.27.6.903 Alving, 1978, Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs, Proc. Natl. Acad. Sci. U.S.A., 75, 2959, 10.1073/pnas.75.6.2959 Koning, 2002, Interference of macrophages with immunotargeting of liposomes, J. Liposome Res., 12, 107, 10.1081/LPR-120004782 Harding, 1997, Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes, Biochim. Biophys. Acta, 1327, 181, 10.1016/S0005-2736(97)00056-4 Barenholz, 2001, Liposome application: problems and prospects, Curr. Opin. Colloid Interface Sci., 6, 66, 10.1016/S1359-0294(00)00090-X Goren, 2000, Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump, Clin. Cancer Res., 6, 1949 Biswas, 2013, Surface functionalization of doxorubicin-loaded liposomes with octa-arginine for enhanced anticancer activity, Eur. J. Pharm. Biopharm., 84, 517, 10.1016/j.ejpb.2012.12.021 Nagahara, 1998, Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration, Nat. Med., 4, 1449, 10.1038/4042 Vives, 1997, A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem., 272, 16010, 10.1074/jbc.272.25.16010 Chen, 2012, Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22, Leuk. Lymphoma, 53, 208, 10.3109/10428194.2011.604755 Peer, 2004, Loading Mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models, Int. J. Cancer, 108, 780, 10.1002/ijc.11615 Yan, 2012, LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor, J. Control. Release, 157, 118, 10.1016/j.jconrel.2011.07.034 Pan, 2003, Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model, Pharm. Res., 20, 417, 10.1023/A:1022656105022 Watanabe, 2012, Functional coating of liposomes using a folate–polymer conjugate to target folate receptors, Int. J. Nanomed., 7, 3679 Xiang, 2008, Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes, Int. J. Pharm., 22, 29, 10.1016/j.ijpharm.2007.12.030 Nishikawa, 2012, Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer, J. Control. Release, 160, 274, 10.1016/j.jconrel.2011.10.010 Xiang, 2011, Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes, J. Control. Release, 152, 402, 10.1016/j.jconrel.2011.03.014 Wu, 2012, Methylene diphosphonate-conjugated adriamycin liposomes: preparation, characteristics, and targeted therapy for osteosarcomas in vitro and in vivo, Biomed. Microdev., 14, 497, 10.1007/s10544-011-9626-3 Hölig, 2004, Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells, Protein Eng. Des. Sel., 17, 433, 10.1093/protein/gzh055 Grange, 2010, Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma, Cancer Res., 70, 2180, 10.1158/0008-5472.CAN-09-2821 Cai, 2014, Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy, Biomaterials, 35, 2283, 10.1016/j.biomaterials.2013.11.088 Paoli, 2014, Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes, J. Control. Release, 178, 108, 10.1016/j.jconrel.2014.01.005 Hatakeyama, 2007, Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes, Int. J. Pharm., 342, 194, 10.1016/j.ijpharm.2007.04.037 Park, 2014, Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery, J. Control. Release, 174, 98, 10.1016/j.jconrel.2013.11.016 Pan, 2005, In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model, Anticancer Res., 25, 343 Ying, 2010, Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, J. Control. Release, 141, 183, 10.1016/j.jconrel.2009.09.020 Chono, 2008, Efficient drug targeting to at alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections, J. Control. Release, 127, 50, 10.1016/j.jconrel.2007.12.011 Koning, 2006, Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis, Arthritis Rheum., 54, 1198, 10.1002/art.21719 Garg, 2009, Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide, Int. J. Pharm., 366, 201, 10.1016/j.ijpharm.2008.09.016 Harata, 2013, CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells, Blood, 104, 1442, 10.1182/blood-2004-02-0588 Drummond, 2000, Current status of pH-sensitive liposomes in drug delivery, Prog. Lipid Res., 39, 409, 10.1016/S0163-7827(00)00011-4 Deshpande, 2013, Current trends in the use of liposomes for tumor targeting, Nanomedicine (Lond), 8, 10.2217/nnm.13.118 Perche, 2013, Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting, J. Drug Deliv., 2013, 1, 10.1155/2013/705265 Simard, 2009, pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells, Int. J. Pharm., 381, 86, 10.1016/j.ijpharm.2009.05.013 Simões, 2001, On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes, Biochim. Biophys. Acta, 1515, 23, 10.1016/S0005-2736(01)00389-3 Ducat, 2011, Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles, Int. J. Pharm., 420, 319, 10.1016/j.ijpharm.2011.08.034 Litzinger, 1992, Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications, Biochim. Biophys. Acta, 1113, 201, 10.1016/0304-4157(92)90039-D Obata, 2010, Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo, J. Control. Release, 142, 267, 10.1016/j.jconrel.2009.10.023 A.M. Gomez, Fusogenic anti-PSMA liposomes for antivascular chemotherapy, 54f. Dissertation (Master), Graduate School New Brunswick Rutgers, The State University of New Jersey and The Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, New Brunswick, 2013, https://rucore.libraries.rutgers.edu/rutgers-lib/41774/PDF/1/. Barros, 2011, Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification, Bioorg. Med. Chem. Lett., 21, 7373, 10.1016/j.bmcl.2011.10.016 Carmo, 2008, Biodistribution study and identification of inflammation sites using 99mTc-labelled stealth pH-sensitive liposomes, Nucl. Med. Commun., 29, 33, 10.1097/MNM.0b013e3282f1bc0d Banerjee, 2012, Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy, Int. J. Pharm., 436, 786, 10.1016/j.ijpharm.2012.07.059 Tannock, 1989, Acid pH in tumors and its potential for therpeutic exploitation, Cancer Res., 49, 4373 Van Sluis, 1999, In vivo imaging of extracellular pH using 1H MRSI, Magn. Reson. Med., 41, 743, 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z Wijesinghe, 2013, pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis, Sci. Rep., 3560, 1 Andreev, 2009, Targeting acidic diseased tissue: new technology based on use of the pH (Low) insertion peptide (pHLIP), Chim. Oggi, 27, 34 Reshetnyak, 2008, Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane, Proc. Natl. Acad. Sci. U.S.A., 105, 15340, 10.1073/pnas.0804746105 Andreev, 2007, Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo, Proc. Natl. Acad. Sci. U.S.A., 104, 7893, 10.1073/pnas.0702439104 Hunt, 1997, Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix, Biochemistry, 36, 15177, 10.1021/bi970147b Reshetnyak, 2007, A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers, Biophys. J., 93, 2363, 10.1529/biophysj.107.109967 Yao, 2013, pHLIP®-mediated delivery of PEGylated liposomes to cancer cells, J. Control. Release, 167, 228, 10.1016/j.jconrel.2013.01.037 Karve, 2010, The pH-dependent association with cancer cells of tunable functionalized lipid vesicles with encapsulated doxorubicin for high cell-kill selectivity, Biomaterials, 31, 4409, 10.1016/j.biomaterials.2010.01.064 Kim, 2009, Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice, J. Control. Release, 140, 55, 10.1016/j.jconrel.2009.07.005 Francis, 2001, In vitro evaluation of pHsensitive polymer/niosome complexes, Biomacromolecules, 2, 741, 10.1021/bm010036z Meyer, 1998, Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes, FEBS Lett., 421, 61, 10.1016/S0014-5793(97)01520-2 Pétriat, 2004, Study of molecular interactions between a phospholipidic layer and a pH-sensitive polymer using the Langmuir balance technique, Langmuir, 20, 1393, 10.1021/la035583f Zignani, 2000, In vitro characterization of a novel polymeric-based pH-sensitive liposome system, Biochim. Biophys. Acta, 1463, 383, 10.1016/S0005-2736(99)00234-5 Liu, 2014, Dynamic disordering of liposomal cocktails and the spatio-temporal favorable release of cargoes to circumvent drug resistance, Biomaterials, 35, 3406, 10.1016/j.biomaterials.2013.12.089 Soares, 2011, Liposomes radiolabeled with 159Gd: in vitro antitumoral activity, biodistribution study and scintigraphic image in Ehrlich tumor bearing mice, Eur. J. Pharm. Sci., 43, 290, 10.1016/j.ejps.2011.05.006 Soares, 2012, Antitumoral activity and toxicity of PEG-coated and PEG-folate-coated pH-sensitive liposomes containing 159Gd-DTPA-BMA in Ehrlich tumor bearing mice, Eur. J. Pharm. Sci., 45, 58, 10.1016/j.ejps.2011.10.018 Yatvin, 1978, Design of liposomes for enhanced local release of drugs by hyperthermia, Science, 202, 1290, 10.1126/science.364652 Weinstein, 1979, Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors, Science, 204, 188, 10.1126/science.432641 Kong, 2000, Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release, Cancer Res., 60, 6950 Needdham, 2000, A new temperature sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model, Cancer Res., 60, 1197 Ponce, 2007, Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects, J. Natl. Cancer Inst., 99, 53, 10.1093/jnci/djk005 Tagami, 2012, A thermosensitive liposome prepared with a Cu2+ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy, J. Control. Release, 161, 142, 10.1016/j.jconrel.2012.03.023 Hildebrandt, 2002, The cellular and molecular basis of hyperthermia, Crit. Rev. Oncol. Hematol., 43, 33, 10.1016/S1040-8428(01)00179-2 Kong, 1999, Hyperthermia and liposomes, Int. J. Hyperthermia, 15, 345, 10.1080/026567399285558 Gong, 2001, Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia, Biol. Pharm. Bull., 34, 1058, 10.1248/bpb.34.1058 Mills, 2005, Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition, Biochim. Biophys. Acta, 1716, 77, 10.1016/j.bbamem.2005.08.007 De Smet, 2010, Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance, J. Control. Release, 143, 120, 10.1016/j.jconrel.2009.12.002 Li, 2014, A novel two-step mild hyperthermia for advanced liposomal chemotherapy, J. Control. Release, 174, 202, 10.1016/j.jconrel.2013.11.012 www.celsion.com. Tagami, 2011, Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin, J. Control. Release, 152, 303, 10.1016/j.jconrel.2011.02.009 Tagami, 2011, MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome, Biomaterials, 32, 10.1016/j.biomaterials.2011.05.029 Kim, 2014, Temperature-triggered tumor-specific delivery of anticancer agentsby cRGD-conjugated thermosensitive liposomes, Colloids Surf. B: Biointerfaces, 116, 17, 10.1016/j.colsurfb.2013.12.045 Van Elk, 2014, Triggered release of doxorubicin from temperature-sensitive poly(N–(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes, Biomacromolecules, 1002, 10.1021/bm401904u Kono, 1999, Thermosensitive polymer-modified liposomes that release contents around physiological temperature, Biochim. Biophys Acta, 1416, 239, 10.1016/S0005-2736(98)00226-0 Kono, 2010, Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy, Biomaterials, 31, 7096, 10.1016/j.biomaterials.2010.05.045 Kono, 2011, Multi-functional liposomes having temperature-triggered release and magnetic resonance imaging for tumor-specific chemotherapy, Biomaterials, 32, 1387, 10.1016/j.biomaterials.2010.10.050 Ta, 2010, Thermosensitive liposomes modified with poly (nisopropylacrylamide-co-propylacrylic acid) copolymers for triggered release of doxorubicin, Biomacromolecules, 11, 1915, 10.1021/bm1004993 Alkan-Onyuksel, 1996, Development of inherently echogenic liposomes as an ultrasonic contrast agent, J. Pharm. Sci., 85, 486, 10.1021/js950407f Huang, 2001, Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents, J. Pharm. Sci., 90, 1917, 10.1002/jps.1142 Buchanan, 2010, Encapsulation of NF-κB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered release, J. Control. Release, 141, 193, 10.1016/j.jconrel.2009.09.017 Newman, 2001, Ultrasound gene therapy: on the road from concept to reality, Echocardiography, 18, 339, 10.1046/j.1540-8175.2001.00339.x Lin, 2014, Ultrasound sensitive eLiposomes containing doxorubicin for drug targeting therapy, Nanomedicine, 10, 67, 10.1016/j.nano.2013.06.011 Faria, 2013, Synthesis and characterization of magnetoliposomes for MRI contrast enhancement, Int. J. Pharm., 446, 183, 10.1016/j.ijpharm.2013.02.025 Frascione, 2012, Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes, Int. J. Nanomed., 7, 2349 Soenen, 2011, MRI assessment of blood outgrowth endothelial cell homing using cationic magnetoliposomes, Biomaterials, 32, 4140, 10.1016/j.biomaterials.2011.02.037 Hamaguchi, 2003, Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model, Cancer Sci., 94, 834, 10.1111/j.1349-7006.2003.tb01527.x Kawai, 2005, Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats, Prostate, 64, 373, 10.1002/pros.20253 Fattahi, 2011, Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics, Nanomedicine, 6, 529, 10.2217/nnm.11.14 Al-Jamal, 2007, Liposome – nanoparticle hybrids for multimodal diagnostic and therapeutic applications, Nanomedicine, 2, 85, 10.2217/17435889.2.1.85 Martina, 2005, Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging, J. Am. Chem. Soc., 127, 10676, 10.1021/ja0516460 Soenen, 2009, Magnetoliposomes: versatile innovative nanocolloids for use in biothecnology and biomedicine, Nanomedicine, 4, 177, 10.2217/17435889.4.2.177 Soenen, 2009, Stable long-term intracellular labelling with fluorescently tagged cationic magnetoliposomes, Chembiochem, 10, 257, 10.1002/cbic.200800510 Rívièri, 2007, Magnetic targeting of nanometric magnetic fluid loaded liposomes to specific brain intravascular areas: a dynamic imaging study in mice, Radiology, 244, 439, 10.1148/radiol.2442060912 Clares, 2013, Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer, Eur. J. Pharm. Biopharm., 85, 329, 10.1016/j.ejpb.2013.01.028 Gonzales, 2005, Synthesis of magnetoliposomes with monodisperse iron oxide nanocrystal cores for hyperthermia, J. Magn. Magn. Mater., 293, 265, 10.1016/j.jmmm.2005.02.020 Tanaka, 2005, Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma, J. Biosci. Bioeng., 100, 112, 10.1263/jbb.100.112 Bonini, 2013, Nanostructures for magnetically triggered release of drugs and biomolecules, Curr. Opin. Colloid Interface Sci., 18, 459, 10.1016/j.cocis.2013.07.007 Qiu, 2013, Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation, Colloids Surf. B: Biointerfaces, 104, 326, 10.1016/j.colsurfb.2012.11.033 Tai, 2009, Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release, Nanotechnology, 20, 1, 10.1088/0957-4484/20/13/135101 Nahar, 2014, Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature, Int. J. Pharm., 464, 185, 10.1016/j.ijpharm.2014.01.007 Bothun, 2011, Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake, Nanomedicine, 7, 797, 10.1016/j.nano.2011.02.007 Jain, 2003, RGD-encored magnetic liposomes for monocytes/neutrophils-mediated brain targeting, Int. J. Pharm., 261, 43, 10.1016/S0378-5173(03)00269-2 Li, 2011, RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studies, Eur. J. Radiol., 80, 598, 10.1016/j.ejrad.2011.01.051 Pradhan, 2010, Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy, J. Control. Release, 142, 108, 10.1016/j.jconrel.2009.10.002 Menon, 2013, Nanomaterials for photo-based diagnostic and therapeutic applications, Theranostics, 3, 152, 10.7150/thno.5327 Zhu, 2013, Stimulus-responsive nanopreparations for tumor targeting, Integr. Biol. (Camb), 5, 1, 10.1039/C2IB20135F de Visscher, 2011, Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the Window-Chamber Tumor Model, Lasers Surg. Med., 43, 528, 10.1002/lsm.21082 Yavlovich, 2010, Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications, Mol. Membr. Biol., 27, 364, 10.3109/09687688.2010.507788 Leung, 2012, Light-activated content release from liposomes, Theranostics, 2, 1020, 10.7150/thno.4847 Wu, 2011, A gold nanoshell with a silica inner shell synthesized using liposome templates for doxorubicin loading and near-infrared photothermal therapy, Int. J. Nanomed., 6, 807 You, 2014, Near-infrared light-sensitive liposomes for the enhanced photothermal tumor treatment by the combination with chemotherapy, Pharm. Res., 31, 554, 10.1007/s11095-013-1180-7 Fan, 2013, Development of liposomal formulations: from concept to clinical investigations, Asian J. Pharm. Sci., 8, 81, 10.1016/j.ajps.2013.07.010 Chang, 2012, Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy, Int. J. Nanomed., 7, 49 Gabizon, 1994, Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes, Cancer Res., 54, 987 Silverman, 2013, Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine, Cancer Chemother. Pharmacol., 71, 555, 10.1007/s00280-012-2042-4 Drummond, 2006, Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy, Cancer Res., 66, 3271, 10.1158/0008-5472.CAN-05-4007 http://clinicaltrials.gov/ct2/show/study/NCT00734682?term=CPT-11+liposomes&rank=8. http://www.clinicaltrials.gov/ct2/show/study/NCT00364143?term=irinotecan+liposomes&rank=1. http://www.clinicaltrials.gov/ct2/show/NCT00765973?term. http://www.exparel.com/pdf/Exparel_Monograph.pdf. Immordino, 2006, Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential, Int. J. Nanomed., 1, 297 http://www.drugs.com/pro/depocyt.html. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf2b4eaf-5227-42d9-af78 88d921e565f6. http://www.drugcoverage.org/Myocet/pdf/736865117ACA44C0B454E5CBD9841D79_Product_Monograph_English_-_June_2006.pdf. https://www.janssenmedicalinformation.com/assets/pdf/products/files/DOXIL/pi/OBI-ENCL-PI-000359.pdf. Chuang, 2010, Endocytosis of PEGylated agents enhances cancer imaging and anticancer efficacy, Mol. Cancer Ther., 9, 1903, 10.1158/1535-7163.MCT-09-0899 http://www.drugs.com/pro/depodur.html.